Tumor-associated Stromal Cells Expressing E-prostanoid 2 or 3 Receptors in Prostate Cancer: Correlation With Tumor Aggressiveness and Outcome by Angiogenesis and Lymphangiogenesis

Sheng, 2001, Prostaglandin E2 increases growth and motility of colorectal carcinoma cells, J Biol Chem, 276, 18075, 10.1074/jbc.M009689200 Chang, 2004, Role of prostaglandin E2-dependent angiogenic switch in cyclooxygenase 2-induced breast cancer progression, Proc Natl Acad Sci USA, 101, 591, 10.1073/pnas.2535911100 Coleman, 1994, International Union of Pharmacology classification of prostanoid receptors: properties, distribution, and structure of the receptors and their subtypes, Pharmacol Rev, 46, 205 Yoshimatsu, 2001, Inducible microsomal prostaglandin E synthase is overexpressed in colorectal adenomas and cancer, Clin Cancer Res, 7, 3971 Nithipatikom, 2002, Requirement of cyclooxygenase-2 expression and prostaglandins for human prostate cancer cell invasion, Clin Exp Metastasis, 19, 593, 10.1023/A:1020915914376 Watanabe, 1999, Role of the prostaglandin E receptor subtype EP1 in colon carcinogenesis, Cancer Res, 59, 5093 Chen, 2000, Prostaglandin E2 and the protein kinase A pathway mediate arachidonic acid induction of c-fos in human prostate cancer cells, Br J Cancer, 82, 2000 Jabbour, 2001, Expression of COX-2 and PGE synthase and synthesis of PGE(2) in endometrial adenocarcinoma: a possible autocrine/paracrine regulation of neoplastic cell function via EP2/EP4 receptors, Br J Cancer, 85, 1023, 10.1054/bjoc.2001.2033 Kawamori, 2001, Chemopreventive effects of ONO-8711, a selective prostaglandin E receptor EP(1) antagonists, on breast cancer development, Carcinogenesis, 22, 2001, 10.1093/carcin/22.12.2001 Sales, 2001, Cyclooxygenase-2 expression and prostaglandin E(2) synthesis are up-regulated in carcinomas of the cervix: a possible autocrine/paracrine regulation of neoplastic cell function via EP2/EP4 receptors, J Clin Endocrinol Metab, 86, 2243, 10.1210/jcem.86.5.7442 Yano, 2002, Prostaglandin E2 reinforces the activation of Ras signal pathway in lung adenocarcinoma cells via EP3, FEBS Lett, 518, 154, 10.1016/S0014-5793(02)02689-3 Robertson, 2010, Differential regulation of the aggressive phenotype of inflammatory breast cancer cells by prostanoid receptors EP3 and EP4, Cancer, 116, 2806, 10.1002/cncr.25167 Hubbard, 2001, Differential mRNA expression of prostaglandin receptor subtypes in macrophage activation, Prostaglandins Leukot Essent Fatty Acids, 65, 287, 10.1054/plef.2001.0327 Ikegami, 2001, The expression of prostaglandin E receptors EP2 and EP4 and their different regulation by lipopolysaccharide in C3H/HeN peritoneal macrophages, J Immunol, 166, 4689, 10.4049/jimmunol.166.7.4689 Nataraj, 2001, Receptors for prostaglandin E(2) that regulate cellular immune responses in the mouse, J Clin Invest, 108, 1229, 10.1172/JCI200113640 Kataki, 2002, Tumor infiltrating lymphocytes and macrophages have a potential dual role in lung cancer by supporting both host-defense and tumor progression, J Lab Clin Med, 140, 320, 10.1067/mlc.2002.128317 Nguyen, 2002, Receptors and signaling mechanisms required for prostaglandin E2-mediated regulation of mast cell degranulation and IL-6 production, J Immunol, 169, 4586, 10.4049/jimmunol.169.8.4586 Georgiannos, 2003, The immunophenotype and activation status of the lymphocytic infiltrate in human breast cancers, the role of the major histocompatibility complex in cell-mediated immune mechanisms, and their association with prognostic indicators, Surgery, 134, 827, 10.1016/S0039-6060(03)00292-7 Utrera-Barillas, 2010, The role of macrophages and mast cells in lymphangiogenesis and angiogenesis in cervical carcinogenesis, Exp Mol Pathol, 89, 190, 10.1016/j.yexmp.2010.06.002 Nakanishi, 2012, PGE2 stimulate VEGF production the EP2 receptor in cultured human lung fibroblasts, Am J Respir Cell Biol, 46, 217, 10.1165/rcmb.2010-0115OC Hosono, 2011, Roles of prostagalnsin E2-EP3/EP4 receptor signaling in enhancement of lymphangiogensis during fibroblast growth factor-2-induced granulation formation, Arterioscler Thromb Vasc Biol, 31, 1049, 10.1161/ATVBAHA.110.222356 Greene, 2002, American Joint Committee on Cancer and American Cancer Society, AJCC, 184 Epstein, 2005, The 2005 International Society of Urological Pathology (ISUP) consensus conference on Gleason grading of prostatic carcinoma, Am J Surg Pathol, 29, 1228, 10.1097/01.pas.0000173646.99337.b1 Iwata, 2008, Lymphangiogenesis and angiogenesis in conventional renal cell carcinoma: association with vascular endothelial growth factors A to D immunohistochemistry, Urology, 71, 749, 10.1016/j.urology.2007.10.063 Miyata, 2006, Relationship between prostaglandin E2 receptors and clinicopathological features in human prostate cancer tissues, Urology, 67, 1360, 10.1016/j.urology.2006.09.035 Seno, 2002, Cyclooxygenase-2 and prostaglandin E(2) receptor EP(2)-dependent angiogenesis in APCΔ716 mouse intestinal polyps, Cancer Res, 62, 506 Abdel-Majid, 2004, Prostaglandin E2 induces degranulation-independent production of vascular endothelial growth factor by human mast cells, J Immunol, 172, 1227, 10.4049/jimmunol.172.2.1227 Oshima, 2004, Hyperplastic gastric tumors induced by activated macrophages in COX-2/mPGES-1 transgenic mice, EMBO J, 23, 1669, 10.1038/sj.emboj.7600170 Kubo, 2010, Host prostaglandin EP3 receptor signaling relevant to tumor-associated lymphangiogenesis, Biomed Pharmacother, 64, 101, 10.1016/j.biopha.2009.04.039